Vermont Disclosure

Information for Vermont Prescribers of Prescription Drugs Provided Pursuant to Vermont's Pharmaceutical Marketer Price Disclosure Law

This information is intended for Vermont Prescribers.

33 V.S.A. § 2005a.

Product Name Short Form Long Form Date updated
Aubagio® (teriflunomide) Aubagio Short Form Aubagio Long Form January 20, 2020
Avalide® (irbesartan and hydrochlorothiazide) Avalide Short Form Avalide Long Form January 20, 2020
Avapro® (irbesartan) Avapro Short Form Avapro Long Form January 20, 2020
Cerdelga (eliglustat) Cerdelga Short Form Cerdelga Long Form January 20, 2020
Multaq (dronedarone) Multaq Short Form Multaq Long Form January 20, 2020
Renvela (sevelamer carbonate) Renvela Short Form Renvela Long Form January 20, 2020
Caprelsa (vandetanib) Caprelsa Short Form Caprelsa Long Form January 20, 2020

Guide to Vermont's Pharmaceutical Marketer Price Disclosure Law, 33 V.S.A. § 2005a. Published by the Vermont Office of the Attorney General.

Please See Full Prescribing Information, including Boxed Warning, for Avalide, AvaproAubagio, Caprelsa and Multaq.